These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 6104307)

  • 1. H-Pro-[3H]Leu-Gly-NH2: metabolism in human and rat plasma investigated by high-pressure liquid chromatography.
    Witter A; Scholtens H; Verhoef J
    Neuroendocrinology; 1980 Jun; 30(6):377-81. PubMed ID: 6104307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. H-Pro-[3H]Leu-Gly-NH2: uptake and metabolism in rat brain.
    de Wildt D; Verhoef J; Witter A
    J Neurochem; 1982 Jan; 38(1):67-74. PubMed ID: 6125567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. H-Pro-[3H]Leu-Gly-NH2: plasma profile and brain uptake following subcutaneous injection in the rat.
    Verhoef J; Prins A; Veldhuis HD; Witter A
    J Neurochem; 1982 Apr; 38(4):1135-8. PubMed ID: 6121002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a radioimmunoassay for Pro-Leu-Gly-NH2 (PLG or MIF-I): evidence that PLG is not present in rat brain.
    Manberg PJ; Youngblood WW; Kizer JS
    Brain Res; 1982 Jun; 241(2):279-84. PubMed ID: 6125241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delayed degradation of Tyr-MIF-1 in neonatal rat plasma.
    Kastin AJ; Hahn K; Banks WA; Zadina JE
    Peptides; 1994; 15(8):1561-3. PubMed ID: 7700856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential metabolism of Tyr-MIF-1 and MIF-1 in rat and human plasma.
    Kastin AJ; Hahn K; Erchegyi J; Zadina JE; Hackler L; Palmgren M; Banks WA
    Biochem Pharmacol; 1994 Feb; 47(4):699-709. PubMed ID: 7907473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of the interaction between pro-leu-gly-NH2 and catecholaminergic drugs on MSH release from rat pituitaries incubated in vitro.
    Vivas A; Celis ME
    Neuroendocrinology; 1982; 35(3):150-4. PubMed ID: 6127639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of metabolism in the action of prolyl-leucyl-glycinamide on the development of tolerance to the analgesic effect of morphine.
    Bhargava HN
    Neuropharmacology; 1986 Jul; 25(7):737-41. PubMed ID: 2875417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New evidence that demonstrates that L-pro-L-leu-L-gly-NH2 might be the natural MIF.
    Vivas A; Celis ME
    Acta Physiol Lat Am; 1977; 27(4):177-82. PubMed ID: 31762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypophysectomy increases TYR-MIF-1-like immunoreactivity in rat plasma.
    Kastin AJ; Dickson JC
    Neuroendocrinology; 1987 Mar; 45(3):177-81. PubMed ID: 2882434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydrolysis of [Leu]enkephalin by chick plasma in vitro.
    Shibanoki S; Weinberger SB; Beniston D; Nudelman KA; Schulteis G; Bennett EL; Rosenzweig MR; Ishikawa K; Martinez JL
    J Pharmacol Exp Ther; 1991 Feb; 256(2):650-5. PubMed ID: 1994000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitive determination of N-terminal prolyl peptides by high-performance liquid chromatography with laser-induced fluorescence detection.
    Toyo'oka T; Ishibashi M; Terao T
    J Chromatogr A; 1994 Feb; 661(1-2):105-12. PubMed ID: 8136900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Separation of alkylaminonaphthylenesulfonyl peptides and amin acids by high-performance liquid chromatography. Methods for measuring melanotropin inhibiting factor breakdown.
    Hui KS; Salschutz M; Davis BA; Lajtha A
    J Chromatogr; 1980 May; 192(2):341-50. PubMed ID: 6104674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure activity relationship studies with hypothalamic peptide hormones. I. Effect of melanotropin release inhibiting factor and analogs on tolerance to morphine in the rat.
    Bhargava HN; Kim HS
    J Pharmacol Exp Ther; 1982 Feb; 220(2):394-8. PubMed ID: 6120229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significant differences in the degradation of pro-leu-gly-nH2 by human serum and that of other species (38484).
    Walter R; Neidle A; Marks N
    Proc Soc Exp Biol Med; 1975 Jan; 148(1):98-103. PubMed ID: 1168915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous peptide Tyr-Pro-Trp-Gly-NH2 (Tyr-W-MIF-1) is transported from the brain to the blood by peptide transport system-1.
    Banks WA; Kastin AJ; Ehrensing CA
    J Neurosci Res; 1993 Aug; 35(6):690-5. PubMed ID: 8105102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Pro-Leu-Gly-NH(2) on plasma levels of ?-MSH in the rat.
    Celis ME; Thody AJ; Fisher C
    Neurochem Int; 1982; 4(1):27-31. PubMed ID: 20487847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. L-dopa potentiating analogs of Pro-Leu-Gly-NH2 with oral efficacy.
    Albrecht HP; Hofman HP; Klebe G; Kreiskott H
    Boll Chim Farm; 1991 Feb; 130(2):55-9. PubMed ID: 1678611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukotriene C4 disposition and metabolism in the anesthetized and endotoxemic dog.
    Pfeifer CA; Bottoms GD; Johnson MA; Fessler J
    Circ Shock; 1991 Feb; 33(2):68-83. PubMed ID: 1675594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of ACTH secretion by synthetic MSH-release inhibiting factor Pro-Leu-Gly-NH2 in Addison's disease.
    Voigt KH; Fehm HL; Lang RE; Beinert KE; Pfeiffer EF
    Horm Metab Res; 1977 Mar; 9(2):150-2. PubMed ID: 16818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.